Arax Advisory Partners’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140K Buy
12,326
+11,629
+1,668% +$114K ﹤0.01% 2500
2026
Q1
$4.4K Buy
697
+474
+213% +$4.27K ﹤0.01% 2845
2025
Q4
$2.38K Buy
223
+87
+64% +$956 ﹤0.01% 3197
2025
Q3
$1.69K Buy
+136
New +$1.39K ﹤0.01% 3151
2025
Q2
Sell
-63
Closed -$498 3073
2025
Q1
$498 Buy
+63
New +$775 ﹤0.01% 2538
2022
Q1
Sell
-13
Closed -$1K 1163
2021
Q4
$1K Buy
+13
New +$1.15K ﹤0.01% 987

Other funds holding CRNC

Arax Advisory Partners's CRNC Position: Q2 2026 in Review

Arax Advisory Partners increased its Cerence (CRNC) stake by 1,668% in Q2 2026, buying an estimated $114K and bringing the position to 12,326 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #2500.

Arax Advisory Partners first reported a position in CRNC in Q4 2021 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Arax Advisory Partners held 12,326 shares of Cerence worth $140K as of Q2 2026.
  • Arax Advisory Partners bought 11,629 Cerence shares in Q2 2026, an estimated $114K.
  • Cerence made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2500 holding.
  • Arax Advisory Partners first reported a position in Cerence in Q4 2021 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.